Powered by
ANN ARBOR–Endra Life Sciences Inc. (Nasdaq: NDRA), developers of Thermo Acoustic Enhanced UltraSound (TAEUS) medical diagnostic technology, announced that it will be effecting a reverse stock split of its outstanding …
ANN ARBOR—ENDRA Life Sciences Inc., developers of thermo acoustic enhanced ultrasound technology for medical diagnosis, announced it had received two new United States Patents—No. 11,456,518, for “Method for Manufacturing a …
ANN ARBOR—The Ann Arbor medical device startup Endra Life Sciences Inc. (Nasdaq: NDRA) announced that it has raised $8.7 million year-to-date from the sale of common stock through its at-the-market …
ANN ARBOR—Officials at Endra Life Sciences Inc. (Nasdaq: NDRA) announced the issuance of Eurpean Patents 3668382 and 36614116 for, respectively, “Method and System for Estimating Fractional Fat Content of an …
ANN ARBOR—Endra Life Sciences Inc. (NASDAQ: NDRA), a developer of ultrasound technologies, today announced it has received Institutional Review Board approval from China’s Shanghai General Hospital for the first clinical …
ANN ARBOR–Endra Life Sciences Inc. (NASDAQ: NDRA), the Ann Arbor-based ultrasound technology developer, has won two new patents from the United States Patent and Trademark Office. They are U.S. Patent …
ANN ARBOR—Officials at Endra Life Sciences Inc. (NASDAQ: NDRA) announced that the company had been issued U.S. Patent 11,147,067 titled, “Method And System For Monitoring Tissue Temperature” from the United …